NexPlasmaGen’s to present at the Seed showcase 2022
NEXPLASMAGEN TO PRESENT AT SEED SHOWCASE 2022 NexPlasmaGen will pitch its business opportunity to investors! Montreal/De...
24 December, 2021 No comment
Latest Posts Small Image
-
-
NexPlasmaGen’s CPJ breast cancer in vivo preclinical trials completed
NexPlasmaGen is proud to announce that the preclinical trials program led by Dr. Philip Wong at the Centre Hospitaller d...
03 November, 2021 No comment -
NexPlasmaGen’s Cold Plasma Technology to Treat Breast Cancer in Preparation for Clinical Investigation
NexPlasmaGen Inc. is pleased to announce that its patented cold plasma technology is in preparation for clinical investi...
02 January, 2021 No comment -
NexPlasmaGen to present at the MedInvest Oncology Investor Conference
Montreal/June 23, 2022 – NexPlasmaGen is honored to present at the MedInvest Oncology Investor Conference. The MedInvest...
23 June, 2022 No comment
-
02 Feb 2023 NexPlasmaGen to present to the OBIO Investment Summit
NEXPLASMAGEN TO PRESENT AT THE 2023 OBIO INVESTMENT SUMMIT Canada’s Premier Health Science Investment Event! Montreal/Fe...
02 February, 2023 No comment -
NexPlasmaGen completed an investment phase to accelerate the development of its cold plasma technology for breast cancer treatment
NexPlasmaGen Inc. is pleased to announce the completion of $795,000 in private and public investment from individuals, A...
01 July, 2018 No comment -
NEXPLASMAGEN is finalist for an ADRIQ innovation award
Montreal / July 4, 2022 NexPlasmaGen is a finalist for the ADRIQ Innovation Award 2022 in the category Innovation from P...
04 July, 2022 No comment -
NexPlasmaGen to present at the 2022 OBIO investment summit
NEXPLASMAGEN TO PRESENT AT THE 2022 OBIO INVESTMENT SUMMIT Canada’s Premier Health Science Investment Event! Montreal/Ja...
30 January, 2022 No comment
